|
HSPA1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.29379999999724E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.625700E-04 |
| Normal-vs-Stage2 |
1.803250E-04 |
| Normal-vs-Stage3 |
1.70586000000084E-05 |
| Normal-vs-Stage4 |
3.968200E-04 |
| Stage1-vs-Stage2 |
9.125000E-01 |
| Stage1-vs-Stage3 |
6.872400E-01 |
| Stage1-vs-Stage4 |
9.586000E-01 |
| Stage2-vs-Stage3 |
7.620200E-01 |
| Stage2-vs-Stage4 |
8.639600E-01 |
| Stage3-vs-Stage4 |
6.074000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.23289999999876E-05 |
| Normal-vs-AfricanAmerican |
2.079700E-03 |
| Normal-vs-Asian |
4.988400E-01 |
| Caucasian-vs-AfricanAmerican |
6.787400E-01 |
| Caucasian-vs-Asian |
6.723700E-02 |
| AfricanAmerican-vs-Asian |
1.663970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.838600E-04 |
| Normal-vs-Female |
3.91329999960277E-07 |
| Male-vs-Female |
5.727400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.118000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.19700000000833E-06 |
| Normal-vs-Age(61-80Yrs) |
2.24999999742792E-08 |
| Normal-vs-Age(81-100Yrs) |
7.129400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.211600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.837600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.492800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.707200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.091600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.043600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.91460000076304E-08 |
| Normal-vs-Grade 2 |
1.95709999983862E-07 |
| Normal-vs-Grade 3 |
2.216400E-02 |
| Normal-vs-Grade 4 |
7.99650000000707E-05 |
| Grade 1-vs-Grade 2 |
1.028390E-01 |
| Grade 1-vs-Grade 3 |
4.879800E-02 |
| Grade 1-vs-Grade 4 |
3.247700E-02 |
| Grade 2-vs-Grade 3 |
2.072200E-01 |
| Grade 2-vs-Grade 4 |
2.906600E-01 |
| Grade 3-vs-Grade 4 |
5.223600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.358500E-03 |
| Normal-vs-ccB subtype |
2.384200E-04 |
| ccA subtype-vs-ccB subtype |
6.330800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.32250000237389E-08 |
| Normal-vs-N1 |
3.043400E-04 |
| N0-vs-N1 |
8.048600E-01 |
|
|
